Motif Biosciences

Liver toxicity concerns spike Motif Bio’s iclaprim filing
Fierce Biotech
Thu, 02/14/19 - 05:55 pm
FDA
Motif Biosciences
ABSSSI
Iclaprim
complete response letter
The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials
Yahoo/Benzinga
Sun, 02/10/19 - 11:08 pm
Motif Biosciences
Iclaprim
Merck
Keytruda
melanoma
JNJ
esketamine
ASCO
Pfizer
Veru. earnings
Aveo Pharmaceuticals
Calithera Biosciences
New antibiotic therapies: what future?
GoinPharma
Mon, 10/23/17 - 10:00 pm
antibiotics
Merck
Paratek
Tetraphase Pharmaceuticals
Motif Biosciences
The Medicines Company
Prescribed Reading: DMD, MS and other acronyms
Biopharma Dive
Sun, 10/8/17 - 11:22 am
Celgene
Nimbus
Endocyte
Amicus Therapeutics
Catabasis
Motif Biosciences
Motif delivers more strong data on its antibiotic
Biopharma Dive
Thu, 10/5/17 - 06:07 pm
Motif Biosciences
antibiotics
Iclaprim
skin infections
Antibiotics firm Motif Bio to tap UK market for cash
Yahoo/Reuters
Sun, 02/1/15 - 10:24 am
Motif Biosciences
antibiotics